Chia Tai Enterprises International Limited (HKG:3839)

Market Cap	686.05M
Revenue (ttm)	3.25B
Net Income (ttm)	139.01M
Shares Out	240.72M
EPS (ttm)	0.55
PE Ratio	5.19
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	795,500
Average Volume	607,295
Open	2.850
Previous Close	2.850
Day's Range	2.710 - 3.210
52-Week Range	0.650 - 3.120
Beta	3.71
RSI	86.48
Earnings Date	Aug 8, 2025

About HKG:3839

Chia Tai Enterprises International Limited manufactures and sells animal health products and chlortetracycline in Mainland China, the Asia Pacific, the Americas, Europe, and internationally. It operates through two segments, Biochemical and Industrial. The Biochemical segment products portfolio consists of CTC premix and CTC hydrochloride, which are used as feed additives to promote growth of livestock, prevent or cure animal diseases, and enhance feed efficiency under the Shihao and Citifac brand names. The Industrial segment engages in the sa...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1987
• Employees: 900
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 3839

Financial Performance

In 2024, HKG:3839's revenue was $307.75 million, an increase of 76.89% compared to the previous year's $173.98 million. Earnings were $11.17 million, an increase of 337.45%.

Financial numbers in USD